Main Blog


Korean NIFDS scientists visit IVI

  On April 25, IVI welcomed a 6-person delegation from the National Institute of Food and Drug SafetyEvaluation (NIFDS) under the Korean Ministry of Food & Drug Safety at our headquarters in Seoul.  They visited IVI to explore potential opportunities in vaccine R&D collaboration as part of NIFDS’ efforts to improve Korea’s vaccine self-sufficiency.

Dr. Soon-Hwan Kwon explores Human adenoviruses at IVI Seminar

  Dr. Soon-Hwan Kwon, Ph.D., Armed Forces Medical Research Institute (AFMRI), gave a lecture entitled “Analysis of adenovirus genotypes and neutralization effects between genotypes” as part of the 2019 IVI Seminar Series: The Present and Future of Vaccine Development, at IVI headquarters in Seoul on […]

WHO health economist Dr. Raymond Hutubessy addresses ‘The Full Public Health Value of Vaccines’ at IVI Seminar

Dr. Raymond Hutubessy with Dr. Vittal Mogasale, Head of IVI’s Policy & Economic Research Department   On April 29, IVI welcomed Dr. Raymond Hutubessy, Senior Economist from the Immunization, Vaccines and Biologicals (IVB), Initiative for Vaccine Research (IVR) at the World Health Organization Headquarters, in Geneva, Switzerland, as […]

IVI hosts Environmental Impact Assessment Workshop

  As part of IVI’s commitment to environmental protection and combating climate change, IVI hosted an Environmental Impact Assessment workshop with the Swedish consultants Goodpoint on May 7, 2019. IVI and Goodpoint are working together on the development of an IVI environmental management plan.